These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 383149)

  • 21. Interaction of nystatin with nystatin-resistant Candida tropicalis.
    Alonso A; Martínez E; Struzinský R; Michaljanicová D; Kotyk A
    Folia Microbiol (Praha); 1983; 28(3):157-62. PubMed ID: 6873771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of phosphatidylserine enrichment on amino acid transport in yeast.
    Trivedi A; Singhal GS; Prasad R
    Biochim Biophys Acta; 1983 Mar; 729(1):85-9. PubMed ID: 6338922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum.
    Barrett-Bee K; Newboult L; Pinder P
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):127-31. PubMed ID: 2060756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ergosterol-enhanced recovery of mutagen treated Candida albicans.
    Sarachek A
    Z Allg Mikrobiol; 1977; 17(6):481-5. PubMed ID: 337692
    [No Abstract]   [Full Text] [Related]  

  • 26. Freeze fracture electron microscopical investigation of Candida albicans cells sensitive and resistant to nystatin.
    Pesti M; Novák EK; Ferenczy L; Svoboda A
    Sabouraudia; 1981 Mar; 19(1):17-26. PubMed ID: 7013113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased permeability of glycerol in an ergosterol-less mutant of Candida albicans.
    Pesti M; Novák R
    Acta Microbiol Hung; 1984; 31(2):81-4. PubMed ID: 6380195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in membrane lipids and amino acid transport in a nystatin-resistant Aspergillus niger.
    Mazumder C; Basu J; Kundu M; Chakrabarti P
    Can J Microbiol; 1990 Jun; 36(6):435-7. PubMed ID: 1975770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages.
    Peterson EM; Calderone RA
    Infect Immun; 1978 Aug; 21(2):506-13. PubMed ID: 357287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
    Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
    Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effect of iridals from saponin injury in Candida albicans cells.
    Leconte O; Bonfils JP; Sauvaire Y
    Phytochemistry; 1997 Feb; 44(4):575-9. PubMed ID: 9041715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.
    Johnson B; White RJ; Williamson GM
    J Gen Microbiol; 1978 Feb; 104(2):325-33. PubMed ID: 24676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proline uptake in Candida albicans.
    Dabrowa N; Howard DH
    J Gen Microbiol; 1981 Dec; 127(2):391-7. PubMed ID: 7045279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
    Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
    J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C; Hampe IAI; Hertlein T; Ohlsen K; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some characteristics of nystatin-resistant sterol mutants of Candida albicans.
    Pesti M; Paku S; Novák EK
    Acta Microbiol Acad Sci Hung; 1982; 29(1):55-66. PubMed ID: 7046355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid uptake as a function of differentiation in Candida albicans: studies of a non-germinative variant.
    Kaur S; Mishra P
    FEMS Microbiol Lett; 1991 Aug; 66(3):341-4. PubMed ID: 1769529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport of basic amino acids in Candida albicans.
    Rao LR; Prasad DS; Prasad R
    Biochim Biophys Acta; 1986 Apr; 856(2):237-43. PubMed ID: 3082361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
    Sun LM; Liao K; Liang S; Yu PH; Wang DY
    J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.